Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
Virus Research|November 8, 2016
Deep sequencing for HIV-1 clinical managementMaria Casadellà, Roger Paredes
Medicina Clinica|June 3, 2004
[Duration of antiretroviral combinations]Roger Paredes, Bonaventura Clotet
Medicina Clinica|November 13, 2013
[Is it posible to reduce the human immunodeficiency virus-associated chronic inflammation?]Muntsa Rocafort, Roger Paredes
Current Opinion in HIV and AIDS|April 18, 2009
Clinical approach to drug resistance interpretation: expert adviceBonaventura Clotet, Roger Paredes
Antiviral Research|October 8, 2009
Clinical management of HIV-1 resistanceRoger Paredes, Bonaventura Clotet
AIDS (London, England)|April 15, 2004
New antiretroviral drugs and approaches to HIV treatmentRoger Paredes, Bonaventura Clotet
The Lancet. Infectious Diseases|November 25, 2023
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19Robert L Gottlieb, Roger Paredes
Current Opinion in HIV and AIDS|January 8, 2025
The rectal microbiome: understanding its role in HIV transmissionFrancesc Català-Moll, Roger Paredes
The Lancet. HIV|September 24, 2016
Next-generation sequencing and HIV drug resistance surveillanceRaph L Hamers, Roger Paredes
The Journal of Infectious Diseases|July 1, 2026
Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and CautionsLillian Seo, Roger Paredes, Rami Kantor
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
Virus Research|November 8, 2016
Deep sequencing for HIV-1 clinical managementMaria Casadellà, Roger Paredes
Medicina Clinica|June 3, 2004
[Duration of antiretroviral combinations]Roger Paredes, Bonaventura Clotet
Medicina Clinica|November 13, 2013
[Is it posible to reduce the human immunodeficiency virus-associated chronic inflammation?]Muntsa Rocafort, Roger Paredes
Current Opinion in HIV and AIDS|April 18, 2009
Clinical approach to drug resistance interpretation: expert adviceBonaventura Clotet, Roger Paredes
Antiviral Research|October 8, 2009
Clinical management of HIV-1 resistanceRoger Paredes, Bonaventura Clotet
AIDS (London, England)|April 15, 2004
New antiretroviral drugs and approaches to HIV treatmentRoger Paredes, Bonaventura Clotet
The Lancet. Infectious Diseases|November 25, 2023
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19Robert L Gottlieb, Roger Paredes
Current Opinion in HIV and AIDS|January 8, 2025
The rectal microbiome: understanding its role in HIV transmissionFrancesc Català-Moll, Roger Paredes
The Lancet. HIV|September 24, 2016
Next-generation sequencing and HIV drug resistance surveillanceRaph L Hamers, Roger Paredes
The Journal of Infectious Diseases|July 1, 2026
Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and CautionsLillian Seo, Roger Paredes, Rami Kantor
Pageof 31